Literature DB >> 3280318

Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope.

K H Kuck1, K P Kunze, M Schlüter, C A Nienaber, A Costard.   

Abstract

Programmed electrical stimulation was performed in 54 consecutive patients with hypertrophic cardiomyopathy. There were 11 'symptomatic' patients: three had a history of cardiac arrest due to ventricular tachyarrhythmias (group A), and eight had a history of syncope of unknown origin (group B); 43 patients were 'asymptomatic', i.e. they had no documented or suspected symptomatic ventricular arrhythmias (group C). There were no differences among the groups with respect to electrocardiographic, echocardiographic or hemodynamic data. Ventricular arrhythmias were induced by atrial and right and left ventricular stimulation with a maximum of two extrastimuli in 18 patients. Induced arrhythmias were repetitive ventricular response in six patients, nonsustained ventricular tachycardia in four, sustained ventricular tachycardia in five, and ventricular fibrillation in three patients. With one exception, ventricular tachycardia was always rapid (cycle lengths ranged from 180 to 250 ms); it was polymorphic in six patients and monomorphic in three. Atrial stimulation induced rapid monomorphic ventricular tachycardia in one group A patient. The type and incidence of induced ventricular arrhythmias did not differ among the three groups. It is concluded that programmed electrical stimulation induces the same type of ventricular arrhythmia (rapid polymorphic ventricular tachycardia or ventricular fibrillation) in 'symptomatic' and 'asymptomatic' patients with hypertrophic cardiomyopathy, the incidence in the latter group being 19%. Induction by atrial stimulation of a rapid ventricular tachycardia may be a specific finding to identify patients with hypertrophic cardiomyopathy at risk for exercise-induced ventricular fibrillation.

Entities:  

Mesh:

Year:  1988        PMID: 3280318     DOI: 10.1093/oxfordjournals.eurheartj.a062472

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  12 in total

Review 1.  Patients with ventricular arrhythmias: who should be referred to an electrophysiologist?

Authors:  John M Morgan
Journal:  Heart       Date:  2002-11       Impact factor: 5.994

Review 2.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 3.  Sudden cardiac death in patients with nonischemic cardiomyopathy.

Authors:  Brian P Betensky; Sanjay Dixit
Journal:  Indian Heart J       Date:  2014-01-06

4.  Long-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic events.

Authors:  Jeffrey P Moak; Eric S Leifer; Dorothy Tripodi; Saidi A Mohiddin; Lameh Fananapazir
Journal:  Pediatr Cardiol       Date:  2011-04-13       Impact factor: 1.655

5.  Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: association with left ventricular apical aneurysm.

Authors:  F Alfonso; M P Frenneaux; W J McKenna
Journal:  Br Heart J       Date:  1989-02

6.  Electrophysiological investigation of patients with hypertrophic cardiomyopathy. Evidence that slowed intraventricular conduction is associated with an increased risk of sudden death.

Authors:  R C Saumarez
Journal:  Br Heart J       Date:  1994-12

7.  Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; F Cecchi; W J McKenna
Journal:  Br Heart J       Date:  1994-12

8.  [A rare cause of syncope in a patient treated with the TASH procedure].

Authors:  C Jabbour; E-M Oenning; J Neuzner; R Gradaus; W A Schöbel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2010-12-19

Review 9.  Management of arrhythmias in hypertrophic cardiomyopathy.

Authors:  J T Stewart; W J McKenna
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

Review 10.  [Limits and scopes of invasive risk stratification. Do we still need programmed ventricular stimulation?].

Authors:  Sascha Rolf; Wilhelm Haverkamp
Journal:  Herz       Date:  2009-11       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.